46 results on '"Oliva, Angelo"'
Search Results
2. Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention
3. Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials
4. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery
5. P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials
6. Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
7. Tailored repetitive transcranial magnetic stimulation for depression and addictions
8. Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
9. Biochemical Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors by Cardiovascular Risk Profile and Volume Status in a Real-World Diabetic Population
10. Transseptal Balloon-Assisted Translocation of the Mitral Anterior Leaflet (BATMAN) in Mitral Valve-in-Ring Implantation
11. Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
12. TCT-728 Impact of Neutrophil-to-Lymphocyte Ratio on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
13. TCT-764 Left Main Percutaneous or Surgical Revascularization and Subsequent Risk of Acute Kidney Injury: The LUCKY Registry
14. Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry.
15. Transseptal Balloon-Assisted Translocation of the Mitral Anterior Leaflet (BATMAN) in Mitral Valve-in-Ring Implantation
16. Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
17. A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service
18. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
19. [SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention]
20. Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold
21. 898 ROLE OF 3D ECHOCARDIOGRAPHY IN AORTIC VALVE ABNORMALITIES: TWO CASES REPORT
22. 730 P2Y12 INHIBITORS MONOTHERAPY IN PATIENTS UNDERGOING COMPLEX VS NON-COMPLEX PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
23. 759 LEFT MAIN PERCUTANEOUS OR SURGICAL REVASCULARIZATION AND SUBSEQUENT RISK OF ACUTE KIDNEY INJURY: INSIGHTS FROM THE LUCKY REGISTRY
24. 760 IMPACT OF COMORBIDITIES AND PATIENTS PREFERENCE ON THE CHOICE BETWEEN PERCUTANEOUS OR SURGICAL REVASCULARIZATION FOR LEFT MAIN CORONARY ARTERY DISEASE
25. 481 VITAMIN K ANTAGONISTS, DIRECT ORAL ANTICOAGULANTS, OR LEFT ATRIAL APPENDAGE CLOSURE FOR PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
26. Is this the conclusive evidence for ticagrelor monotherapy in acute coronary syndromes?
27. TCT-539 Left Main Percutaneous or Surgical Revascularization and Subsequent Risk of Acute Kidney Injury: Insights From the LUCKY Registry
28. 112 Safety and biochemical efficacy of sodium–glucose cotransporter 2 inhibitors based on cardiovascular risk profile and volume status in a real-world diabetic population
29. 617 Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population
30. Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
31. CLINICAL IMPACT OF PROCEDURAL COMPLEXITY AND HIGH BLEEDING RISK STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.
32. Il processo di identificazione del potenziale donatore di organi e tessuti all’interno delle strutture sanitarie (Procurement): Una revisione della letteratura
33. Integrated Procurement Model: A new approach to Tissue and Organ Procurement.
34. Il processo di identificazione del potenziale donatore di organi e tessuti all'interno delle strutture sanitarie (Procurement): Una revisione della letteratura.
35. IMPACT OF POLYVASCULAR DISEASE ON MORTALITY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE.
36. INFLAMMATION AND CONTRAST ASSOCIATED ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.
37. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease. Two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC)
38. Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
39. Significance of diabetes mellitus status in patients undergoing percutaneous left main coronary artery intervention.
40. [Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond].
41. Immediate and follow-up outcomes of drug-coated balloon angioplasty in de novo long lesions on large coronary arteries.
42. Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease.
43. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).
44. [SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention].
45. [Presentation].
46. Tailored repetitive transcranial magnetic stimulation for depression and addictions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.